Skip to main content

Activation of spinal dorsal horn astrocytes by noxious stimuli involves descending noradrenergic signaling

Abstract

Astrocytes are critical regulators of neuronal function in the central nervous system (CNS). We have previously shown that astrocytes in the spinal dorsal horn (SDH) have increased intracellular Ca2+ levels following intraplantar injection of the noxious irritant, formalin. However, the underlying mechanisms remain unknown. We investigated these mechanisms by focusing on the role of descending noradrenergic (NAergic) signaling because our recent study revealed the essential role of the astrocytic Ca2+ responses evoked by intraplantar capsaicin. Using in vivo SDH imaging, we found that the Ca2+ level increase in SDH astrocytes induced by intraplantar formalin injection was suppressed by ablation of SDH-projecting locus coeruleus (LC)-NAergic neurons. Furthermore, the formalin-induced Ca2+ response was dramatically decreased by the loss of α1A-adrenaline receptors (ARs) in astrocytes located in the superficial laminae of the SDH. Moreover, similar inhibition was observed in mice pretreated intrathecally with an α1A-AR-specific antagonist. Therefore, activation of α1A-ARs via descending LC-NAergic signals may be a common mechanism underlying astrocytic Ca2+ responses in the SDH evoked by noxious stimuli, including chemical irritants.

Astrocytes, which are abundant glial cells in the CNS, have become increasingly recognized as critical elements regulating neuronal function [1] including somatosensory information processing in the spinal dorsal horn (SDH) [2, 3] and brain [4]. By using a method of in vivo Ca2+ imaging in the SDH [5], several studies have shown that SDH astrocytes have increased intracellular Ca2+ levels ([Ca2+]i) following strong mechanical pressure (pinch) to the hindpaw [6] and intraplantar injection of chemical irritants (capsaicin and formalin) [7, 8], suggesting that SDH astrocytes respond to noxious stimuli in the periphery. However, the mechanism underlying the increase in astrocytic [Ca2+]i is not fully understood. Our recent study demonstrated that [Ca2+]i increases in SDH astrocytes after intraplantar capsaicin are mediated by the activation of α1A-adrenaline receptors (α1A-ARs) through descending noradrenergic (NAergic) neurons from the locus coeruleus (LC) to the SDH [7]. However, whether the α1A-AR-mediated descending LC-NAergic signals commonly contribute to astrocytic Ca2+ responses evoked by noxious stimuli remains unclear. In this study, we investigated astrocytic Ca2+ responses to noxious irritant formalin using multiple approaches, including in vivo Ca2+ imaging, circuit-specific neuronal ablation, conditional gene knockout, and pharmacological intervention.

For in vivo Ca2+ imaging in SDH astrocytes, the Ca2+ indicator, GCaMP6m, was selectively expressed in SDH astrocytes following microinjection of an adeno-associated virus (AAV) vector expressing GCaMP6m under the control of the astrocytic promoter, gfaABC1D, into the left SDH (Additional file 1: Figure S1; Additional file 2), as reported previously [7, 8]. Using GCaMP6m-expressing mice under anesthesia, we confirmed that intraplantar injection of formalin, but not vehicle, induced robust increases in [Ca2+]i in SDH astrocytes (Fig. 1a). To examine the involvement of the descending LC-NAergic pathway, we employed a circuit-specific ablation method using diphtheria toxin (DTX) and its receptor (DTR). To ablate SDH-projecting LC-NAergic neurons, AAVretro-Cre was microinjected into the left SDH of wild-type mice, and AAV-FLEX-DTR-EGFP or AAV-FLEX-AcGFP (control) was injected into the bilateral LC (Fig. 1b). In these mice, GFP expression was observed in the LC, and GFP+ LC neurons were immunolabeled with an antibody for tyrosine hydroxylase (TH), a marker for catecholaminergic neurons (mostly NAergic neurons in the LC) (Fig. 1c). Systemic administration of DTX eliminated GFP+ LC neurons in mice with AAV-FLEX-DTR-EGFP, but not in those with AAV-FLEX-AcGFP (Fig. 1c). In GCaMP6m-expressing mice with an ablation of descending LC-NAergic neurons, we found that the percentage of SDH astrocytes with increased [Ca2+]i evoked by intraplantar formalin injection was significantly lower (Fig. 1d). The average trace of Ca2+ responses and the area under the curve (AUC) of Ca2+ traces from individual SDH astrocytes during the first 600 s after formalin injection were also suppressed. These results indicate that the descending LC-NAergic pathway contributes to formalin-induced astrocytic Ca2+ responses in SDH.

Fig. 1
figure1

Intraplantar injection of formalin activates SDH astrocytes via α1A-ARs through descending LC-NAergic signals. a Averaged trace and AUC during the first 600 s (AUC0–600 s) of astrocytic Ca2+ signals in the SDH after intraplantar injection of vehicle or formalin (vehicle, n = 47 ROIs, 4 mice; formalin, n = 123 ROIs, 4 mice, ****P < 0.0001, Mann–Whitney U test). b Schematic illustration of retrograde transduction strategy in descending LC-NAergic neurons using the FLEX-switch system. c Representative images of LC-NAergic neurons in mice treated with PBS or DTX administration. GFP (green), and TH (red). df SDH astrocytic Ca2+ responses by formalin in mice with ablation of descending LC-NAergic neurons (d), conditional knockout of α1A-ARs in Hes5+ astrocytes (Adra1a-cKO; Hes5-CreERT2;Adra1aflox/flox) compared with control mice (control; Adra1aflox/flox) (e), and pretreatment intrathecally with PBS or silodosin (3 nmol) (f). Percentage of responding astrocytes (d control, n = 6 mice; ablated, n = 6 mice; e: control, n = 5 mice; Adra1a-cKO, n = 5 mice; f PBS, n = 6 mice; silodosin, n = 6 mice, *P < 0.05, **P < 0.01, ****P < 0.0001, unpaired t-test); averaged trace and AUC (d control, n = 255 ROIs; ablated, n = 263 ROIs; e control, n = 253 ROIs; Adra1a-cKO, n = 224 ROIs; f PBS, n = 364 ROIs; silodosin, n = 296 ROIs, ****P < 0.0001, Mann–Whitney U test). Data show the mean ± SEM

We previously identified α1A-AR as an astrocyte-expressing receptor necessary for Ca2+ responses evoked by intraplantar capsaicin [7]. Consistent with our previous study [7], immunohistochemical analysis confirmed that 96.5 ± 1.9% of SDH astrocytes expressed α1A-ARs (Additional file 1: Figure S2). Thus, we examined the role of α1A-AR using Hes5-CreERT2;Adra1aflox/flox mice (treated with tamoxifen) that lack this receptor in SDH astrocytes, especially localized in superficial laminae [7]. The number of SDH astrocytes with increased [Ca2+]i by formalin in Adra1aflox/flox control mice (Control) was dramatically decreased in Hes5-CreERT2;Adra1aflox/flox mice (Adra1a-cKO) (Fig. 1e). The average trace and AUC for Ca2+ responses were also lower in Adra1a-cKO mice than in control mice. Adra1a-cKO mice treated with tamoxifen also lack α1A-AR expression in brain Hes5+ astrocytes [7]. To determine the importance of α1A-ARs in the spinal cord, we intrathecally administered the α1A-AR-specific antagonist, silodosin, before formalin injection. Silodosin-pretreated mice also showed marked inhibition of the formalin-induced astrocytic Ca2+ responses (the percentage of SDH astrocytes with [Ca2+]i increases, the average trace of Ca2+ responses, and their AUCs) (Fig. 1f). Taken together, the Ca2+ responses in SDH astrocytes following formalin injection are mediated by the activation of α1A-ARs through descending LC-NAergic signals.

In this study, we demonstrate for the first time that intraplantar injection of the noxious irritant, formalin, activates SDH astrocytes (especially the Hes5+ subset) via α1A-ARs stimulated by descending LC-NAergic signaling. Previous data showing induction of the neuronal activity marker c-FOS in LC-NAergic neurons [9] supports our findings. Given that astrocytic Ca2+ responses in the SDH after intraplantar capsaicin are mediated by α1A-AR-mediated descending LC-NAergic signaling [7], this raises the possibility that this signaling pathway from the LC-NAergic neurons to SDH astrocytes is a common mechanism for astrocytic Ca2+ responses in the SDH evoked by noxious chemical irritants. However, the decrease in the number of responding astrocytes was slightly lower in mice with LC-NAergic neuron ablation than in mice with conditional α1A-AR-knockout and silodosin pretreatment. This could be due to incomplete ablation of LC-NAergic neurons projecting to the 4th lumbar SDH where astrocytic Ca2+ responses were monitored or the involvement of other descending NAergic pathways, for example, from regions A5 and A7 (although the LC is the main source of NA in the SDH [10]). In addition, considering the residual astrocytic Ca2+ responses observed in mice either with genetic knockout or pharmacological blockade of α1A-ARs, it seems that other neurotransmitters, such as glutamate, GABA, and ATP, which are known to cause astrocytic Ca2+ elevations [11], may also be involved. Nevertheless, our findings indicate that α1A-AR-mediated descending LC-NAergic signals are a primary driver of Ca2+ responses in SDH astrocytes evoked by noxious stimuli.

In this study, there were different patterns of the average traces of Ca2+ responses after intraplantar formalin injection among experiments. The reason for this difference remains unclear. Nevertheless, Ca2+ responses during several minutes after the injection are commonly observed and are consistent with our previous data [8]. However, Ca2+ responses in Adra1aflox/flox and Hes5-CreERT2;Adra1aflox/flox mice were different from others. It may involve a genetic factor (and/or tamoxifen treatment) because the genetic background of Adra1aflox/flox mice was derived from BDF1 [(C57BL/6 × DBA/2)F1] strain and these mice were not fully backcrossed on the C57BL/6 background, while other experiments used C57BL/6 mice.

Formalin is used as a model for acute and persistent inflammatory pain associated with peripheral tissue injury. The role of spinal NAergic signals in formalin-induced pain has been examined in many studies [12, 13], but it remains controversial. For example, intrathecal treatment with α2-AR agonists reduces formalin pain [12, 14], intrathecal treatment with anti-dopamine-β-hydroxylase antibody-conjugated saporin, which kills SDH-projecting NAergic neurons, attenuates formalin pain [15]. An explanation for this discrepancy may be partly associated with the action of NA in SDH astrocytes. It should be noted that we measured the astrocytic Ca2+ responses for the first 10 min after formalin injection, a time period that corresponds to acute phase of formalin-induced nociceptive behavior. Further investigations using a tool to manipulate Ca2+ responses specifically in Hes5+ SDH astrocytes will uncover their in vivo role in nociceptive information processing and behaviors evoked by formalin.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its Additional file.

Abbreviations

AAV:

Adeno-associated virus

AR:

Adrenaline receptor

AUC:

Area under the curve

DTR:

Diphtheria toxin receptor

DTX:

Diphtheria toxin

Hes5:

Hairy and enhancer of split 5

LC:

Locus coeruleus

NA:

Noradrenaline

SDH:

Spinal dorsal horn

TH:

Tyrosine hydroxylase

References

  1. 1.

    Ben Haim L, Rowitch DH. Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci. 2017;18(1):31–41.

    Article  Google Scholar 

  2. 2.

    Ji RR, Donnelly CR, Nedergaard M. Astrocytes in chronic pain and itch. Nat Rev Neurosci. 2019;20(11):667–85.

    CAS  Article  Google Scholar 

  3. 3.

    Tsuda M. Modulation of pain and itch by spinal glia. Neurosci Bull. 2018;34(1):178–85.

    Article  Google Scholar 

  4. 4.

    Kim SK, Hayashi H, Ishikawa T, Shibata K, Shigetomi E, Shinozaki Y, et al. Cortical astrocytes rewire somatosensory cortical circuits for peripheral neuropathic pain. J Clin Invest. 2016;126(5):1983–97.

    Article  Google Scholar 

  5. 5.

    Farrar MJ, Bernstein IM, Schlafer DH, Cleland TA, Fetcho JR, Schaffer CB. Chronic in vivo imaging in the mouse spinal cord using an implanted chamber. Nat Methods. 2012;9(3):297–302.

    CAS  Article  Google Scholar 

  6. 6.

    Sekiguchi KJ, Shekhtmeyster P, Merten K, Arena A, Cook D, Hoffman E, et al. Imaging large-scale cellular activity in spinal cord of freely behaving mice. Nat Commun. 2016;7:11450.

    Article  Google Scholar 

  7. 7.

    Kohro Y, Matsuda T, Yoshihara K, Kohno K, Koga K, Katsuragi R, et al. Spinal astrocytes in superficial laminae gate brainstem descending control of mechanosensory hypersensitivity. Nat Neurosci. 2020;23(11):1376–87.

    CAS  Article  Google Scholar 

  8. 8.

    Yoshihara K, Matsuda T, Kohro Y, Tozaki-Saitoh H, Inoue K, Tsuda M. Astrocytic Ca2+ responses in the spinal dorsal horn by noxious stimuli to the skin. J Pharmacol Sci. 2018;137(1):101–4.

    CAS  Article  Google Scholar 

  9. 9.

    Imbe H, Okamoto K, Donishi T, Kawai S, Enoki K, Senba E, et al. Activation of ERK in the locus coeruleus following acute noxious stimulation. Brain Res. 2009;1263:50–7.

    CAS  Article  Google Scholar 

  10. 10.

    Li Y, Hickey L, Perrins R, Werlen E, Patel AA, Hirschberg S, et al. Retrograde optogenetic characterization of the pontospinal module of the locus coeruleus with a canine adenoviral vector. Brain Res. 2016;1641(Pt B):274–90.

    CAS  Article  Google Scholar 

  11. 11.

    Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19(2):182–9.

    CAS  Article  Google Scholar 

  12. 12.

    Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol. 2006;80(2):53–83.

    CAS  Article  Google Scholar 

  13. 13.

    Llorca-Torralba M, Borges G, Neto F, Mico JA, Berrocoso E. Noradrenergic Locus Coeruleus pathways in pain modulation. Neuroscience. 2016;338:93–113.

    CAS  Article  Google Scholar 

  14. 14.

    Takano Y, Yaksh TL. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther. 1992;261(2):764–72.

    CAS  PubMed  Google Scholar 

  15. 15.

    Martin WJ, Gupta NK, Loo CM, Rohde DS, Basbaum AI. Differential effects of neurotoxic destruction of descending noradrenergic pathways on acute and persistent nociceptive processing. Pain. 1999;80(1–2):57–65.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank the University of Pennsylvania vector core for providing pZac2.1, pAAV2/9, and pAd DeltaF6 plasmids and Prof. Verdon Taylor (University of Basel, Basel, Switzerland) for providing Hes5-CreERT2 mice. We would like to thank Editage (www.editage.com) for English language editing.

Funding

This work was supported by JSPS KAKENHI Grant Numbers JP19K22500, JP19H05658, JP20H05900 (M.T.), by the Core Research for Evolutional Science and Technology (CREST) program from AMED under Grant Number JP20gm0910006 (M.T.), and by Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant Number JP20am0101091 (M.T.). K.Y. was research fellows of the JSPS (19J21063).

Author information

Affiliations

Authors

Contributions

RK designed experiments, performed almost all experiments, analyzed the data and wrote the manuscript. KY designed experiments and performed intrathecal drug administration. IH provided Adra1aflox/flox mice. MT conceived this project, supervised the overall project, designed experiments and wrote the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Makoto Tsuda.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

All authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1

. Immunohistochemical identification of GCaMP6m-expressing cells in the SDH. Spinal cord sections from mice with microinjection of AAV-gfaABC1D-GCaMP6m into the SDH were immunostained by cell-type-specific markers (SOX9 and GFAP, astrocytes; NeuN, neurons; IBA1, microglia; APC, oligodendrocytes) (red). Note that GCaMP6m-expressing cells (green) were positive to astrocyte markers (SOX9 and GFAP) but were negative to other markers (NeuN, IBA1 and APC). Scale bar, 20 μm. Figure S2. Immunohistochemical analysis of α1A-AR expression in SDH astrocytes. Immunofluorescence of α1A-AR (green) and GFAP (magenta) in the SDH of wild-type mice. Scale bar, 20 μm. Percentage of α1A-AR+ astrocytes per total SDH astrocytes (n = 166 cells, 9 slices from 3 mice). Data show the mean ± SEM.

Additional file 2

. Methods.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kawanabe, R., Yoshihara, K., Hatada, I. et al. Activation of spinal dorsal horn astrocytes by noxious stimuli involves descending noradrenergic signaling. Mol Brain 14, 79 (2021). https://doi.org/10.1186/s13041-021-00788-5

Download citation